Preimplantation Genetic Testing (PGT)

PGT allows analysis of embryos obtained through IVF before transfer to the uterus, enabling the detection of genetic abnormalities. This helps select healthy embryos and avoid the transmission of serious hereditary diseases.

• PGT-A (Aneuploidy Screening)
  Detects chromosomal abnormalities such as trisomy 21 (Down syndrome). Recommended for couples with repeated IVF failures or miscarriages.
• PGT-M (Monogenic disease screening)
  Screens for specific genetic disorders (e.g., cystic fibrosis, muscular dystrophy), allowing couples with known mutations to conceive a child free of the disease.
• PGT-SR (Structural chromosomal abnormality screening)
  Designed for couples with structural chromosomal abnormalities (translocations, inversions), reducing risks of miscarriage or developmental issues.

Why choose these tests?

• Risk Reduction: Helps select the healthiest embryos and minimize genetic risks.
• Increased Success Rates: By identifying and excluding embryos with genetic abnormalities, these tests improve the chances of a successful pregnancy carried to term.
• Tailored Solutions: Each test is designed to meet specific needs, such as recurrent miscarriage, genetic diseases, or chromosomal issues.